Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

2.

Effects of benidipine and some other calcium channel blockers on the prognosis of patients with vasospastic angina. Cohort study with evaluation of the ergonovine coronary spasm induction test.

Io K, Minatoguchi S, Nishigaki K, Ojio S, Tanaka T, Segawa T, Matsuo H, Watanabe S, Hattori A, Ueno K, Ono H, Hiei K, Sato H, Morita N, Noda T, Kato T, Kawasaki M, Takemura G, Fujiwara H.

Arzneimittelforschung. 2007;57(9):573-81.

PMID:
17966756
3.

Effects of combination therapy with angiotensin II type I receptor blockers and calcium channel blockers on renal function in hypertensive patients/a retrospective, "real-world" comparative study.

Yamada H, Suga N, Maeda K, Kimura Y, Miura N, Futenma A, Imai H.

Arzneimittelforschung. 2010;60(2):64-70. doi: 10.1055/s-0031-1296250.

PMID:
20329653
4.

Prognostic effects of benidipine in patients with vasospastic angina: comparison with diltiazem and amlodipine.

Fukumoto Y, Yasuda S, Ito A, Shimokawa H.

J Cardiovasc Pharmacol. 2008 Mar;51(3):253-7. doi: 10.1097/FJC.0b013e3181624b05.

PMID:
18356689
5.

Clinical efficacy of benidipine for vasospastic angina pectoris.

Suzuki H, Yokoyama K, Akimoto Y, Daida H.

Arzneimittelforschung. 2007;57(1):20-5.

PMID:
17341005
6.

Short-acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction. Secondary Prevention Group.

Ishikawa K, Nakai S, Takenaka T, Kanamasa K, Hama J, Ogawa I, Yamamoto T, Oyaizu M, Kimura A, Yamamoto K, Yabushita H, Katori R.

Circulation. 1997 May 20;95(10):2368-73.

7.

Impact of circadian amplitude and chronotherapy: relevance to prevention and treatment of stroke.

Shinagawa M, Kubo Y, Otsuka K, Ohkawa S, Cornélissen G, Halberg F.

Biomed Pharmacother. 2001;55 Suppl 1:125s-132s.

PMID:
11774859
8.

Prognostic effects of calcium channel blockers in patients with vasospastic angina--a meta-analysis.

Nishigaki K, Inoue Y, Yamanouchi Y, Fukumoto Y, Yasuda S, Sueda S, Urata H, Shimokawa H, Minatoguchi S.

Circ J. 2010 Sep;74(9):1943-50. Epub 2010 Jul 21.

9.

Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients.

Kloner RA, Vetrovec GW, Materson BJ, Levenstein M.

Am J Cardiol. 1998 Jan 15;81(2):163-9.

PMID:
9591899
10.

Lesion severity and hypercholesterolemia determine long-term prognosis of vasospastic angina treated with calcium channel antagonists.

Yamagishi M, Ito K, Tsutsui H, Miyazaki S, Goto Y, Nagaya N, Sumiyoshi T, Fukami K, Haze K, Kitakaze M, Nonogi H, Tomoike H.

Circ J. 2003 Dec;67(12):1029-35.

11.
12.

Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: a randomized controlled trial.

Matsuzaki M, Ogihara T, Umemoto S, Rakugi H, Matsuoka H, Shimada K, Abe K, Suzuki N, Eto T, Higaki J, Ito S, Kamiya A, Kikuchi K, Suzuki H, Tei C, Ohashi Y, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial Group.

J Hypertens. 2011 Aug;29(8):1649-59. doi: 10.1097/HJH.0b013e328348345d.

PMID:
21610513
13.
14.

Effects of calcium antagonist, benidipine, on the progression of chronic renal failure in the elderly: a 1-year follow-up.

Suzuki H, Saruta T; Calcium Antagonist in Progressive Renal Insufficienct Study Group.

Clin Exp Hypertens. 2001 Apr;23(3):189-201.

PMID:
11339686
15.

Effects of long-acting versus short-acting calcium channel blockers among older survivors of acute myocardial infarction.

Gillman MW, Ross-Degnan D, McLaughlin TJ, Gao X, Spiegelman D, Hertzmark E, Goldman L, Soumerai SB.

J Am Geriatr Soc. 1999 May;47(5):512-7.

PMID:
10323641
16.
17.

Effects of benidipine in a rat model for experimental angina.

Ikeda J, Matsubara M, Yao K.

Yakugaku Zasshi. 2006 Dec;126(12):1377-81.

18.

Vasospastic angina and Ca channel blockers.

Minatoguchi S.

Curr Hypertens Rev. 2013 Aug;9(3):219-23. Review.

PMID:
24479747
19.

Supplemental Content

Support Center